Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Publisher Correction: Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women.

Hoyles L, Fernández-Real JM, Federici M, Serino M, Abbott J, Charpentier J, Heymes C, Luque JL, Anthony E, Barton RH, Chilloux J, Myridakis A, Martinez-Gili L, Moreno-Navarrete JM, Benhamed F, Azalbert V, Blasco-Baque V, Puig J, Xifra G, Ricart W, Tomlinson C, Woodbridge M, Cardellini M, Davato F, Cardolini I, Porzio O, Gentileschi P, Lopez F, Foufelle F, Butcher SA, Holmes E, Nicholson JK, Postic C, Burcelin R, Dumas ME.

Nat Med. 2018 Aug 9. doi: 10.1038/s41591-018-0169-5. [Epub ahead of print]

PMID:
30093731
2.

Lixisenatide requires a functional gut-vagus nerve-brain axis to trigger insulin secretion in controls and type 2 diabetic mice.

Charpentier J, Waget A, Klopp P, Magnan C, Cruciani-Guglielmacci C, Lee SJ, Burcelin R, Grasset E.

Am J Physiol Gastrointest Liver Physiol. 2018 Aug 2. doi: 10.1152/ajpgi.00348.2017. [Epub ahead of print]

PMID:
30070580
3.

Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women.

Hoyles L, Fernández-Real JM, Federici M, Serino M, Abbott J, Charpentier J, Heymes C, Luque JL, Anthony E, Barton RH, Chilloux J, Myridakis A, Martinez-Gili L, Moreno-Navarrete JM, Benhamed F, Azalbert V, Blasco-Baque V, Puig J, Xifra G, Ricart W, Tomlinson C, Woodbridge M, Cardellini M, Davato F, Cardolini I, Porzio O, Gentileschi P, Lopez F, Foufelle F, Butcher SA, Holmes E, Nicholson JK, Postic C, Burcelin R, Dumas ME.

Nat Med. 2018 Jul;24(7):1070-1080. doi: 10.1038/s41591-018-0061-3. Epub 2018 Jun 25. Erratum in: Nat Med. 2018 Aug 9;:.

PMID:
29942096
4.

Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health.

Laurans L, Venteclef N, Haddad Y, Chajadine M, Alzaid F, Metghalchi S, Sovran B, Denis RGP, Dairou J, Cardellini M, Moreno-Navarrete JM, Straub M, Jegou S, McQuitty C, Viel T, Esposito B, Tavitian B, Callebert J, Luquet SH, Federici M, Fernandez-Real JM, Burcelin R, Launay JM, Tedgui A, Mallat Z, Sokol H, Taleb S.

Nat Med. 2018 Aug;24(8):1113-1120. doi: 10.1038/s41591-018-0060-4. Epub 2018 Jun 25.

PMID:
29942089
5.

Author Correction: Obese Subjects With Specific Gustatory Papillae Microbiota and Salivary Cues Display an Impairment to Sense Lipids.

Besnard P, Christensen JE, Brignot H, Bernard A, Passilly-Degrace P, Nicklaus S, Pais de Barros JP, Collet X, Lelouvier B, Servant F, Blasco-Baque V, Verges B, Lagrost L, Feron G, Burcelin R.

Sci Rep. 2018 Jun 22;8(1):9773. doi: 10.1038/s41598-018-27701-w.

6.

Obese Subjects With Specific Gustatory Papillae Microbiota and Salivary Cues Display an Impairment to Sense Lipids.

Besnard P, Christensen JE, Brignot H, Bernard A, Passilly-Degrace P, Nicklaus S, Pais de Barros JP, Collet X, Lelouvier B, Servant F, Blasco-Baque V, Verges B, Lagrost L, Feron G, Burcelin R.

Sci Rep. 2018 Apr 30;8(1):6742. doi: 10.1038/s41598-018-24619-1. Erratum in: Sci Rep. 2018 Jun 22;8(1):9773.

7.

Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model.

Briand F, Brousseau E, Quinsat M, Burcelin R, Sulpice T.

Eur J Pharmacol. 2018 Jan 5;818:449-456. doi: 10.1016/j.ejphar.2017.11.021. Epub 2017 Nov 16.

PMID:
29155143
8.

Gut Microbiota Interacts with Markers of Adipose Tissue Browning, Insulin Action and Plasma Acetate in Morbid Obesity.

Moreno-Navarrete JM, Serino M, Blasco-Baque V, Azalbert V, Barton RH, Cardellini M, Latorre J, Ortega F, Sabater-Masdeu M, Burcelin R, Dumas ME, Ricart W, Federici M, Fernández-Real JM.

Mol Nutr Food Res. 2018 Feb;62(3). doi: 10.1002/mnfr.201700721. Epub 2017 Dec 29.

PMID:
29105287
9.

Europe has to step up its efforts to produce innovative and safe diabetes technology.

Cnop M, Klupa T, Tentolouris N, Novials A, Burcelin R, van Eimeren M.

Diabetologia. 2017 Dec;60(12):2532-2533. doi: 10.1007/s00125-017-4455-4. Epub 2017 Sep 24. No abstract available.

PMID:
28942556
10.

A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism.

Grasset E, Puel A, Charpentier J, Collet X, Christensen JE, Tercé F, Burcelin R.

Cell Metab. 2017 Jul 5;26(1):278. doi: 10.1016/j.cmet.2017.06.003. No abstract available.

11.

[Gut microbiota and immune crosstalk in metabolic disease].

Burcelin R.

Biol Aujourdhui. 2017;211(1):1-18. doi: 10.1051/jbio/2017008. Epub 2017 Jul 6. Review. French.

PMID:
28682223
12.

Corrupted adipose tissue endogenous myelopoiesis initiates diet-induced metabolic disease.

Luche E, Robert V, Cuminetti V, Pomié C, Sastourné-Arrey Q, Waget A, Arnaud E, Varin A, Labit E, Laharrague P, Burcelin R, Casteilla L, Cousin B.

Elife. 2017 Jun 28;6. pii: e23194. doi: 10.7554/eLife.23194.

13.

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.

Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Mannerås-Holm L, Ståhlman M, Olsson LM, Serino M, Planas-Fèlix M, Xifra G, Mercader JM, Torrents D, Burcelin R, Ricart W, Perkins R, Fernàndez-Real JM, Bäckhed F.

Nat Med. 2017 Jul;23(7):850-858. doi: 10.1038/nm.4345. Epub 2017 May 22.

PMID:
28530702
14.

A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism.

Grasset E, Puel A, Charpentier J, Collet X, Christensen JE, Tercé F, Burcelin R.

Cell Metab. 2017 May 2;25(5):1075-1090.e5. doi: 10.1016/j.cmet.2017.04.013. Erratum in: Cell Metab. 2017 Jul 5;26(1):278.

15.

Capparis spinosa L. aqueous extract evokes antidiabetic effect in streptozotocin-induced diabetic mice.

Eddouks M, Lemhadri A, Hebi M, El Hidani A, Zeggwagh NA, El Bouhali B, Hajji L, Burcelin R.

Avicenna J Phytomed. 2017 Mar-Apr;7(2):191-198.

16.

Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism.

Nicolas S, Blasco-Baque V, Fournel A, Gilleron J, Klopp P, Waget A, Ceppo F, Marlin A, Padmanabhan R, Iacovoni JS, Tercé F, Cani PD, Tanti JF, Burcelin R, Knauf C, Cormont M, Serino M.

Mol Syst Biol. 2017 Mar 16;13(3):921. doi: 10.15252/msb.20167356.

17.

Periodontal Tissue Regeneration Using Syngeneic Adipose-Derived Stromal Cells in a Mouse Model.

Lemaitre M, Monsarrat P, Blasco-Baque V, Loubières P, Burcelin R, Casteilla L, Planat-Bénard V, Kémoun P.

Stem Cells Transl Med. 2017 Feb;6(2):656-665. doi: 10.5966/sctm.2016-0028. Epub 2016 Sep 16.

18.

When gut fermentation controls satiety: A PYY story.

Burcelin R.

Mol Metab. 2016 Nov 21;6(1):10-11. doi: 10.1016/j.molmet.2016.11.005. eCollection 2017 Jan. No abstract available.

19.

Associations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice.

Blasco-Baque V, Coupé B, Fabre A, Handgraaf S, Gourdy P, Arnal JF, Courtney M, Schuster-Klein C, Guardiola B, Tercé F, Burcelin R, Serino M.

Diabetologia. 2017 Apr;60(4):690-700. doi: 10.1007/s00125-017-4209-3. Epub 2017 Jan 19.

PMID:
28105518
20.

[Microbiotes and metabolic diseases: the bases for therapeutic strategies].

Burcelin R, Nicolas S, Blasco-Baque V.

Med Sci (Paris). 2016 Nov;32(11):952-960. doi: 10.1051/medsci/20163211010. Epub 2016 Dec 23. Review. French.

21.

Reply.

Lelouvier B, Servant F, Courtney M, Burcelin R, Amar J.

Hepatology. 2017 May;65(5):1776-1777. doi: 10.1002/hep.28986. Epub 2017 Mar 30. No abstract available.

PMID:
27997979
22.

Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial.

Stenman LK, Lehtinen MJ, Meland N, Christensen JE, Yeung N, Saarinen MT, Courtney M, Burcelin R, Lähdeaho ML, Linros J, Apter D, Scheinin M, Kloster Smerud H, Rissanen A, Lahtinen S.

EBioMedicine. 2016 Nov;13:190-200. doi: 10.1016/j.ebiom.2016.10.036. Epub 2016 Oct 26.

23.

Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis.

Lelouvier B, Servant F, Païssé S, Brunet AC, Benyahya S, Serino M, Valle C, Ortiz MR, Puig J, Courtney M, Federici M, Fernández-Real JM, Burcelin R, Amar J.

Hepatology. 2016 Dec;64(6):2015-2027. doi: 10.1002/hep.28829.

PMID:
27639192
24.

High-fat diet modifies the PPAR-γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine.

Tomas J, Mulet C, Saffarian A, Cavin JB, Ducroc R, Regnault B, Kun Tan C, Duszka K, Burcelin R, Wahli W, Sansonetti PJ, Pédron T.

Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):E5934-E5943. Epub 2016 Sep 16.

25.

Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity.

Burcelin R, Gourdy P.

Obes Rev. 2017 Jan;18(1):86-98. doi: 10.1111/obr.12465. Epub 2016 Sep 16. Review.

PMID:
27636208
26.

Gut microbiota and immune crosstalk in metabolic disease.

Burcelin R.

Mol Metab. 2016 Jun 6;5(9):771-81. doi: 10.1016/j.molmet.2016.05.016. eCollection 2016 Sep. Review.

27.

A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction.

Mavilio M, Marchetti V, Fabrizi M, Stöhr R, Marino A, Casagrande V, Fiorentino L, Cardellini M, Kappel B, Monteleone I, Garret C, Mauriello A, Monteleone G, Farcomeni A, Burcelin R, Menghini R, Federici M.

Cell Rep. 2016 Aug 23;16(8):2269. doi: 10.1016/j.celrep.2016.07.078. Epub 2016 Aug 29. No abstract available.

28.

Gestational diabetes is associated with changes in placental microbiota and microbiome.

Bassols J, Serino M, Carreras-Badosa G, Burcelin R, Blasco-Baque V, Lopez-Bermejo A, Fernandez-Real JM.

Pediatr Res. 2016 Dec;80(6):777-784. doi: 10.1038/pr.2016.155. Epub 2016 Aug 4.

PMID:
27490741
29.

A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction.

Mavilio M, Marchetti V, Fabrizi M, Stöhr R, Marino A, Casagrande V, Fiorentino L, Cardellini M, Kappel B, Monteleone I, Garret C, Mauriello A, Monteleone G, Farcomeni A, Burcelin R, Menghini R, Federici M.

Cell Rep. 2016 Jul 19;16(3):731-43. doi: 10.1016/j.celrep.2016.06.027. Epub 2016 Jun 30. Erratum in: Cell Rep. 2016 Aug 23;16(8):2269.

30.

Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia.

Pomié C, Blasco-Baque V, Klopp P, Nicolas S, Waget A, Loubières P, Azalbert V, Puel A, Lopez F, Dray C, Valet P, Lelouvier B, Servant F, Courtney M, Amar J, Burcelin R, Garidou L.

Mol Metab. 2016 Mar 28;5(6):392-403. doi: 10.1016/j.molmet.2016.03.004. eCollection 2016 Jun.

31.

Young microbes for adult obesity.

Serino M, Nicolas S, Trabelsi MS, Burcelin R, Blasco-Baque V.

Pediatr Obes. 2017 Aug;12(4):e28-e32. doi: 10.1111/ijpo.12146. Epub 2016 May 2. Review.

PMID:
27135640
32.

Erratum: Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals.

Montagner A, Korecka A, Polizzi A, Lippi Y, Blum Y, Canlet C, Tremblay-Franco M, Gautier-Stein A, Burcelin R, Yen YC, Je HS, Al-Asmakh M, Mithieux G, Arulampalam V, Lagarrigue S, Guillou H, Pettersson S, Wahli W.

Sci Rep. 2016 Apr 20;6:23951. doi: 10.1038/srep23951. No abstract available.

33.

Periodontal dysbiosis linked to periodontitis is associated with cardiometabolic adaptation to high-fat diet in mice.

Branchereau M, Reichardt F, Loubieres P, Marck P, Waget A, Azalbert V, Colom A, Padmanabhan R, Iacovoni JS, Giry A, Tercé F, Heymes C, Burcelin R, Serino M, Blasco-Baque V.

Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G1091-101. doi: 10.1152/ajpgi.00424.2015. Epub 2016 Mar 31.

34.

Post-prandial hypoglycemia results from a non-glucose-dependent inappropriate insulin secretion in Roux-en-Y gastric bypassed patients.

Vaurs C, Brun JF, Bertrand M, Burcelin R, du Rieu MC, Anduze Y, Hanaire H, Ritz P.

Metabolism. 2016 Mar;65(3):18-26. doi: 10.1016/j.metabol.2015.10.020. Epub 2015 Oct 23.

PMID:
26892512
35.

Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals.

Montagner A, Korecka A, Polizzi A, Lippi Y, Blum Y, Canlet C, Tremblay-Franco M, Gautier-Stein A, Burcelin R, Yen YC, Je HS, Al-Asmakh M, Mithieux G, Arulampalam V, Lagarrigue S, Guillou H, Pettersson S, Wahli W.

Sci Rep. 2016 Feb 16;6:20127. doi: 10.1038/srep20127. Erratum in: Sci Rep. 2016;6:23951. Maha, Al-Asmakh [corrected to Al-Asmakh, Maha].

36.

Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing.

Païssé S, Valle C, Servant F, Courtney M, Burcelin R, Amar J, Lelouvier B.

Transfusion. 2016 May;56(5):1138-47. doi: 10.1111/trf.13477. Epub 2016 Feb 10.

PMID:
26865079
37.

Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response.

Blasco-Baque V, Garidou L, Pomié C, Escoula Q, Loubieres P, Le Gall-David S, Lemaitre M, Nicolas S, Klopp P, Waget A, Azalbert V, Colom A, Bonnaure-Mallet M, Kemoun P, Serino M, Burcelin R.

Gut. 2017 May;66(5):872-885. doi: 10.1136/gutjnl-2015-309897. Epub 2016 Feb 2.

38.

Gut Microbiota Cool-Down Burning Fat! The Immune Hypothesis.

Burcelin R, Pomié C.

Trends Endocrinol Metab. 2016 Feb;27(2):67-68. doi: 10.1016/j.tem.2015.12.002. Epub 2015 Dec 30.

PMID:
26747615
39.

Establishing a causal link between gut microbes, body weight gain and glucose metabolism in humans - towards treatment with probiotics.

Stenman LK, Burcelin R, Lahtinen S.

Benef Microbes. 2016 Feb;7(1):11-22. doi: 10.3920/BM2015.0069. Epub 2015 Nov 13. Review.

PMID:
26565087
40.

The Characterization of Novel Tissue Microbiota Using an Optimized 16S Metagenomic Sequencing Pipeline.

Lluch J, Servant F, Païssé S, Valle C, Valière S, Kuchly C, Vilchez G, Donnadieu C, Courtney M, Burcelin R, Amar J, Bouchez O, Lelouvier B.

PLoS One. 2015 Nov 6;10(11):e0142334. doi: 10.1371/journal.pone.0142334. eCollection 2015.

41.

Gut Microbiota Interacts With Brain Microstructure and Function.

Fernandez-Real JM, Serino M, Blasco G, Puig J, Daunis-i-Estadella J, Ricart W, Burcelin R, Fernández-Aranda F, Portero-Otin M.

J Clin Endocrinol Metab. 2015 Dec;100(12):4505-13. doi: 10.1210/jc.2015-3076. Epub 2015 Oct 7.

PMID:
26445114
42.

Probiotic B420 and prebiotic polydextrose improve efficacy of antidiabetic drugs in mice.

Stenman LK, Waget A, Garret C, Briand F, Burcelin R, Sulpice T, Lahtinen S.

Diabetol Metab Syndr. 2015 Sep 12;7:75. doi: 10.1186/s13098-015-0075-7. eCollection 2015.

43.

The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORγt and Controls Metabolic Disease.

Garidou L, Pomié C, Klopp P, Waget A, Charpentier J, Aloulou M, Giry A, Serino M, Stenman L, Lahtinen S, Dray C, Iacovoni JS, Courtney M, Collet X, Amar J, Servant F, Lelouvier B, Valet P, Eberl G, Fazilleau N, Douin-Echinard V, Heymes C, Burcelin R.

Cell Metab. 2015 Jul 7;22(1):100-12. doi: 10.1016/j.cmet.2015.06.001.

44.

Diabetes: Antibiotics or prodiabetics?

Burcelin R, Amar J.

Nat Rev Endocrinol. 2015 Jul;11(7):385-6. doi: 10.1038/nrendo.2015.75. Epub 2015 May 19. No abstract available.

PMID:
25986108
45.

CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice.

Poggi M, Morin SO, Bastelica D, Govers R, Canault M, Bernot D, Georgelin O, Verdier M, Burcelin R, Olive D, Alessi MC, Peiretti F, Nunès JA.

Int J Obes (Lond). 2015 Jun;39(6):977-85. doi: 10.1038/ijo.2015.26. Epub 2015 Mar 16.

PMID:
25771927
46.

Interrelationship between lymphocytes and leptin in fat depots of obese mice revealed by changes in nutritional status.

Lolmède K, Zakaroff-Girard A, Dray C, Renoud ML, Daviaud D, Burcelin R, Lafontan M, Galitzky J, Bouloumié A.

J Physiol Biochem. 2015 Sep;71(3):497-507. doi: 10.1007/s13105-015-0388-x. Epub 2015 Feb 12.

PMID:
25670497
47.

Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance.

Denou E, Lolmède K, Garidou L, Pomie C, Chabo C, Lau TC, Fullerton MD, Nigro G, Zakaroff-Girard A, Luche E, Garret C, Serino M, Amar J, Courtney M, Cavallari JF, Henriksbo BD, Barra NG, Foley KP, McPhee JB, Duggan BM, O'Neill HM, Lee AJ, Sansonetti P, Ashkar AA, Khan WI, Surette MG, Bouloumié A, Steinberg GR, Burcelin R, Schertzer JD.

EMBO Mol Med. 2015 Mar;7(3):259-74. doi: 10.15252/emmm.201404169.

48.

Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences.

Serino M, Blasco-Baque V, Nicolas S, Burcelin R.

Curr Cardiol Rep. 2014 Nov;16(11):540. doi: 10.1007/s11886-014-0540-1. Review.

49.

Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice.

Stenman LK, Waget A, Garret C, Klopp P, Burcelin R, Lahtinen S.

Benef Microbes. 2014 Dec;5(4):437-45. doi: 10.3920/BM2014.0014.

PMID:
25062610
50.

Changes in lipoprotein kinetics associated with type 2 diabetes affect the distribution of lipopolysaccharides among lipoproteins.

Vergès B, Duvillard L, Lagrost L, Vachoux C, Garret C, Bouyer K, Courtney M, Pomié C, Burcelin R.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1245-53. doi: 10.1210/jc.2013-3463. Epub 2014 Apr 2.

PMID:
24694333

Supplemental Content

Loading ...
Support Center